A Plus Biotechnology Co., Ltd.

NT$71.90As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6918Healthcare
Country Taiwan
PE (Fwd) •••
TSR 4Y CAGR 12.49%
Div yield 6.95%
ROE 15.50%
Medical Devices
Beta (5Y) 0.10
PE TTM 13.32
TSR TTM (9.70%)
Mkt cap NT$2.450B
ROIC 21.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$73
0.90%
(53.51%)
Hold 4|2|7|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.71
0.77
0.87
0.85
4.39%
3.42%
21.63%
19.07%
RevenueNT$M
188.4
191.7
192.0
199.7
6.71%
2.85%
2.26%
9.63%
Peers (US$73.99M)
Cap (US$)
PE
76.16M
23.43x
71.32M
12.80x
66.47M
9.594x
Capital
TTM
5Y
10Y
Leveragex
0.638
0.400
0.339
EBIT/Intx
0.923
1.299
0.861
Own earn%
77.18
199.34
198.60
Sh yield%
15.39
46.83
44.65
Owners
Insiders/Inst%
2.93
56.79
Short interest%
1.84
SBC / revenue%
3.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
8–10
$1 testx
—
Incr. ROIC%
4